Intratumoural tilsotolimod shows no benefit for advanced refractory melanoma Presented ByProf. Caroline Robert, Gustave Roussy, France TrialPhase 3, ILLUMINATE-301 ConferenceASCO 2024 TypePeer-reviewed article 18 July 2024 14:09